GRCh38/hg38 17p13.3(chr17:2473511-2594380)x3 AND See cases

This record was updated by the submitter. Please see the current version.

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jun 3, 2011
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000137570.4

Allele description

GRCh38/hg38 17p13.3(chr17:2473511-2594380)x3

Genes:

LOC130059961:ATAC-STARR-seq lymphoblastoid active region 11494 [Gene]
LOC130059962:ATAC-STARR-seq lymphoblastoid active region 11495 [Gene]
LOC130059963:ATAC-STARR-seq lymphoblastoid active region 11496 [Gene]
LOC130059960:ATAC-STARR-seq lymphoblastoid silent region 8004 [Gene]
LOC130059964:ATAC-STARR-seq lymphoblastoid silent region 8006 [Gene]
LOC130059965:ATAC-STARR-seq lymphoblastoid silent region 8007 [Gene]
LOC129390821:MPRA-validated peak2683 silencer [Gene]
METTL16:methyltransferase 16, RNA N6-adenosine [Gene - HGNC]
PAFAH1B1:platelet activating factor acetylhydrolase 1b regulatory subunit 1 [Gene - OMIM - HGNC]

Variant type:

copy number gain

Cytogenetic location:

17p13.3

Genomic location:

Preferred name:

GRCh38/hg38 17p13.3(chr17:2473511-2594380)x3

HGVS:

NC_000017.11:g.(?_2473511)_(2594380_?)dup
NC_000017.10:g.(?_2376805)_(2497674_?)dup
NC_000017.9:g.(?_2323555)_(2444424_?)dup

Links:

dbVar: nssv1415467; dbVar: nsv817511

Observations:

Condition(s)

Name:: See cases [See the Variation display for details]
Identifiers:

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000177800	ISCA site 1 See additional submitters International Standards For Cytogenomic Arrays Consortium (ISCA)	no assertion criteria provided	Uncertain significance (Jun 3, 2011)	not provided	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000177800

ISCA site 1

See additional submitters

no assertion criteria provided

Uncertain significance
(Jun 3, 2011)

not provided

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	not provided	yes	1	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, Church DM, Crolla JA, Eichler EE, Epstein CJ, Faucett WA, Feuk L, Friedman JM, Hamosh A, Jackson L, Kaminsky EB, Kok K, Krantz ID, Kuhn RM, Lee C, Ostell JM, Rosenberg C, et al.

Am J Hum Genet. 2010 May 14;86(5):749-64. doi: 10.1016/j.ajhg.2010.04.006. Review.

PubMed [citation]

PMID:: 20466091
PMCID:: PMC2869000

Details of each submission

From ISCA site 1, SCV000177800.4

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	not provided	yes	not provided	not provided	Discovery		1	not provided	not provided	not provided

Last Updated: Oct 14, 2023

ClinVar

Relating variation to medicine